Exicure, Inc.Exicure, Inc.Exicure, Inc.

Exicure, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.86 M‬USD
−1.5589USD
‪−16.91 M‬USD
‪4.49 M‬
Beta (1Y)
1.61

About Exicure, Inc.

CEO
Paul Kang
Headquarters
Chicago
Employees (FY)
6
Founded
2011
FIGI
BBG00GTJCSB4
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of XCUR is 0.3303 USD — it has increased by 0.67% in the past 24 hours. Watch Exicure, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Exicure, Inc. stocks are traded under the ticker XCUR.
XCUR stock has fallen by 2.85% compared to the previous week, the month change is a 7.48% fall, over the last year Exicure, Inc. has showed a 70.77% decrease.
XCUR reached its all-time high on Sep 18, 2018 with the price of 195.0000 USD, and its all-time low was 0.3000 USD and was reached on May 24, 2024. View more price dynamics on XCUR chart.
See other stocks reaching their highest and lowest prices.
XCUR stock is 6.22% volatile and has beta coefficient of 1.61. Track Exicure, Inc. stock price on the chart and check out the list of the most volatile stocks — is Exicure, Inc. there?
Today Exicure, Inc. has the market capitalization of ‪2.86 M‬, it has increased by 1.56% over the last week.
Yes, you can track Exicure, Inc. financials in yearly and quarterly reports right on TradingView.
Exicure, Inc. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
XCUR net income for the last quarter is ‪−829.00 K‬ USD, while the quarter before that showed ‪−1.49 M‬ USD of net income which accounts for 44.25% change. Track more Exicure, Inc. financial stats to get the full picture.
No, XCUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 15, 2024, the company has 6.00 employees. See our rating of the largest employees — is Exicure, Inc. on this list?
Like other stocks, XCUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exicure, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Exicure, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Exicure, Inc. stock shows the sell signal. See more of Exicure, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.